Simpson R U, Franceschi R T, DeLuca H F
J Biol Chem. 1980 Nov 10;255(21):10160-6.
Cytosol prepared from vitamin D3-deficient kidney cells in culture contains a 3.7 S protein that specifically binds 1,25-dihydroxyvitamin D3 with high affinity and low capacity. Whole kidney homogenate cytosol preparations are shown to possess two 1,25-dihydroxyvitamin D3 binding macromolecules. One of the binding proteins sediments at 3.5 to 3.7 S while the second sediments at 6.0 S. The 6.0 S component has a greater affinity for 25-dihydroxyvitamin D3 than for 1,25-dihydroxyvitamin D3. Cultured cell cytosol was found to have little 6.0 S 25-hydroxyvitamin D3 binding protein. Scatchard analysis of the cultured cell cytosol reveals an equilibrium binding constant (KD) of 5.6 x 10 (-11) with 57 fmol of sites/mg of protein. The receptor-like protein has a Mr = 72,000 and as with other steroid receptors it aggregates in the presence of low potassium concentrations. Analog competition for receptor binding reveals the following potency order: 1,25-dihydroxyvitamin D3 > 25-hydroxyvitamin D3 > 1 alpha-hydroxyvitamin D3 > 24(R),25-dihydroxyvitamin D3; the receptor had no detectable affinity for vitamin D3. The kidney cells respond to 1,25-dihydroxyvitamin D3 by diminishing 25-hydroxyvitamin D3 1 alpha-hydroxylation and increasing 24R-hydroxylation. Cultured cells provide a preparation of cytosol which has allowed extensive characterization of the renal 1,25-dihydroxyvitamin D3 receptor and should facilitate investigations into the role this receptor plays in renal control of vitamin D3 metabolism.
从培养的维生素D3缺乏的肾细胞制备的胞质溶胶含有一种3.7S的蛋白质,它能以高亲和力和低容量特异性结合1,25-二羟维生素D3。全肾匀浆胞质溶胶制剂显示具有两种1,25-二羟维生素D3结合大分子。其中一种结合蛋白沉降系数为3.5至3.7S,而另一种沉降系数为6.0S。6.0S组分对25-二羟维生素D3的亲和力比对1,25-二羟维生素D3的亲和力更大。发现培养的细胞胞质溶胶几乎没有6.0S的25-羟维生素D3结合蛋白。对培养的细胞胞质溶胶进行Scatchard分析,结果显示平衡结合常数(KD)为5.6×10(-11),每毫克蛋白质有57fmol的结合位点。这种受体样蛋白的分子量为72,000,与其他类固醇受体一样,在低钾浓度下会聚集。受体结合的类似物竞争显示出以下效力顺序:1,25-二羟维生素D3>25-二羟维生素D3>1α-羟维生素D3>24(R),25-二羟维生素D3;该受体对维生素D3没有可检测到的亲和力。肾细胞对1,25-二羟维生素D3的反应是减少25-二羟维生素D3的1α-羟化并增加24R-羟化。培养的细胞提供了一种胞质溶胶制剂,这使得能够对肾1,25-二羟维生素D3受体进行广泛的表征,并应有助于研究该受体在肾对维生素D3代谢控制中所起的作用。